Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these ...

Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...

New research reveals people with visual snow syndrome experience heightened face pareidolia, mistaking everyday objects for ...

For generations, adults with amblyopia were told their vision loss was permanent, a childhood problem that medicine could not meaningfully reverse later in life. A new wave of research from MIT and ...

Mirror box therapy was initially developed by V. S. Ramachandran. The purpose of this new medical device was to try to reduce what was described as “phantom limb pain.” Mirror box therapy is defined ...

After traumatic brain injury (TBI), some patients may recover completely, while others retain severe disabilities. Accurately evaluating prognosis is challenging in patients on life-sustaining therapy ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

Therapy for neurodivergent adults could include trauma-informed care, sensory sensitivity, support for masking burnout, and flexibility in communication styles and pace. If you’re neurodivergent, or ...